WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2011157416) TRANSDERMAL ADMINISTRATION OF MEMANTINE
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2011/157416    International Application No.:    PCT/EP2011/002953
Publication Date: 22.12.2011 International Filing Date: 15.06.2011
IPC:
A61K 9/70 (2006.01), A61K 31/13 (2006.01)
Applicants: LTS LOHMANN THERAPIE-SYSTEME AG [DE/DE]; Lohmannstr. 2 56626 Andernach (DE) (For All Designated States Except US).
GRÜNENTHAL GMBH [DE/DE]; Zieglerstrasse 6 52078 Aachen (DE) (For All Designated States Except US).
HORSTMANN, Michael [DE/DE]; (DE) (For US Only).
EIFLER, René [DE/DE]; (DE) (For US Only).
KAUFMANN, Regine [DE/DE]; (DE) (For US Only).
MOHR, Patrick [DE/DE]; (DE) (For US Only).
GALIA, Eric [DE/DE]; (DE) (For US Only).
PRANGE, Wolfgang [DE/DE]; (DE) (For US Only).
BULLER, Stefan [DE/DE]; (DE) (For US Only).
PUSECKER, Klaus [DE/DE]; (DE) (For US Only).
STAMPFUSS, Jan [DE/DE]; (DE) (For US Only).
STOELBEN, Susanne [DE/DE]; (DE) (For US Only)
Inventors: HORSTMANN, Michael; (DE).
EIFLER, René; (DE).
KAUFMANN, Regine; (DE).
MOHR, Patrick; (DE).
GALIA, Eric; (DE).
PRANGE, Wolfgang; (DE).
BULLER, Stefan; (DE).
PUSECKER, Klaus; (DE).
STAMPFUSS, Jan; (DE).
STOELBEN, Susanne; (DE)
Agent: SIEMUND, Volker; LTS LOHMANN THERAPIE-SYSTEME AG Patentabteilung Postfach 15 25 56605 Andernach (DE)
Priority Data:
10 2010 024 105.9 17.06.2010 DE
Title (DE) TRANSDERMALE VERABREICHUNG VON MEMANTIN
(EN) TRANSDERMAL ADMINISTRATION OF MEMANTINE
(FR) ADMINISTRATION TRANSDERMIQUE DE MÉMANTINE
Abstract: front page image
(DE)Die Erfindung betrifft transdermale therapeutische Systeme (TTS), welche als Wirkstoff den NMDA Rezeptor Antagonisten Memantin oder eines seiner physiologisch verträglichen Salze enthalten. Die TTS können zur Behandlung von Erkrankungen des Zentralnervensystems hergestellt und eingesetzt werden.
(EN)The invention relates to transdermal therapeutic systems (TTS) which contain as active substance the NMDA receptor antagonist memantine or one of its physiologically acceptable salts. The TTS can be prepared and employed for the treatment of diseases of the central nervous system.
(FR)L'invention concerne des systèmes thérapeutiques transdermiques (TTS) contenant comme principe actif de la mémantine, antagoniste du récepteur NMDA, ou un de ses sels physiologiquement acceptables. Les TTS peuvent être produits et utilisés pour traiter des maladies du système nerveux central.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: German (DE)
Filing Language: German (DE)